Is Oticon or ReSound better in 2026?

Both are top-five prescription brands from Danish manufacturers, but they lead with different strengths. Oticon's 2024 flagship, the Oticon Intent, was the first hearing aid with 4D Sensor technology — it reads your head movement, body movement, and conversation to adjust automatically, built on Oticon's BrainHearing philosophy and deep neural network sound processing. ReSound's 2026 flagship, the Nexia, was among the first hearing aids built on Bluetooth LE Audio with Auracast broadcast support, and the ReSound ONE's M&RIE microphone placement gives it some of the most natural sound localization in the category. Buyers who want automatic, sensor-driven adjustment tend to pick Oticon; buyers who prioritize natural sound and future-proof streaming tend to pick ReSound.

Are Oticon and ReSound hearing aids over the counter or prescription?

Both are prescription-only. Oticon and ReSound hearing aids are fitted and programmed by a licensed audiologist using real-ear measurement, so you cannot self-fit or buy a working unit directly on Amazon. ReSound's parent company also sells a related OTC line if you'd rather skip the clinic — see the question below. Oticon's parent company, Demant, does not sell its own OTC hearing aid line.

How much do Oticon and ReSound hearing aids cost?

Oticon typically runs $2,500 to $7,000 per pair, with the flagship Oticon Intent pricing around $5,000-$7,000 and the value-tier Oticon More landing around $3,000-$5,000. ReSound typically runs $2,500 to $6,000 per pair, with the flagship Nexia pricing around $4,000-$6,000 and the value flagship OMNIA landing around $3,000-$5,000. Both sit at or above the roughly $3,000-per-pair average for prescription hearing aids reported by the President's Council of Advisors on Science and Technology (PCAST).

Which brand has a cheaper OTC alternative?

ReSound does, directly. ReSound is made by GN Hearing, which also makes the OTC Jabra Enhance Select — about $1,195-$1,995 a pair, built on related GN sound engineering. Oticon's parent, Demant, doesn't sell its own OTC line, so Oticon's own review page instead points budget-minded buyers to a third-party OTC device like Jabra Enhance Select, Apple's AirPods Pro 3 (~$249), or budget brand MDHearing. If a same-parent OTC sibling matters to you, that's ReSound's clearest edge over Oticon.

What's the difference between Oticon's 4D Sensor and ReSound's M&RIE?

They solve different problems. Oticon's 4D Sensor technology (debuted on the Intent) uses onboard motion sensors to detect whether you're sitting still, walking, or in conversation, then automatically shifts amplification and noise settings without you touching a control — it's about hands-free adaptation to your activity. ReSound's M&RIE (Microphone & Receiver-In-Ear, on the ReSound ONE) places a third microphone down in your own ear canal so it can use your ear's natural shape to localize where sound is coming from — it's about making sound feel more realistic, not about automatically changing settings.

Oticon vs ReSound Hearing Aids 2026: 4D Sensor AI vs Bluetooth LE Audio

Quick Answer: For most buyers cross-shopping premium prescription hearing aids, Oticon wins on automatic, sensor-driven adjustment — its 2024 flagship, the Oticon Intent, was the first hearing aid with 4D Sensor technology, using motion sensors and Oticon’s BrainHearing philosophy to shift settings for you as your activity changes. ReSound’s Nexia counters with Bluetooth LE Audio and Auracast broadcast support (among the first hearing aids built on the standard) plus the ReSound ONE’s M&RIE natural-sound localization. Both are prescription-only, fitted by an audiologist, and typically run $2,500-$7,000 per pair — in line with the ~$3,000 average reported by the President’s Council of Advisors on Science and Technology (PCAST).

Oticon and ReSound are two of the “big five” global hearing-aid makers, and both trace back to Danish hearing-care heritage — Oticon through parent company Demant (roots to 1904), ReSound through parent company GN (roots to 1869). Where they split is philosophy and connectivity strategy, and only one of them also sells a cheaper OTC sibling from the same parent company. Here’s how the two flagships and supporting lineups actually compare.

Oticon vs ReSound at a glance, by the numbers

4D Sensor technology is an Oticon-first — the Oticon Intent (2024) was the first hearing aid to read head movement, body movement, conversation, and the acoustic environment together to adjust automatically, per Oticon.
Bluetooth LE Audio with Auracast is a ReSound-first — the ReSound Nexia was promoted as one of the first hearing aids in the world built on the new low-energy audio standard, per GN Hearing, ahead of most rivals including Oticon.
1904 vs 1869 — Oticon’s parent Demant traces its hearing-care roots to 1904; ReSound’s parent GN traces its roots to 1869, making GN the older of the two hearing-care lineages even though ReSound as a brand name dates to 1943.
$5,000-$7,000 vs $4,000-$6,000 — Oticon’s flagship Intent typically runs $5,000-$7,000 a pair, while ReSound’s flagship Nexia typically runs $4,000-$6,000 a pair, both above the roughly $3,000 PCAST average for a prescription pair.
28.8 million U.S. adults could benefit from a hearing aid per the NIDCD (National Institute on Deafness and Other Communication Disorders), yet fewer than one in three adults over 70 who could benefit has ever used one — the underserved market both premium brands compete for.

Oticon vs ReSound: head-to-head

Factor	Oticon	ReSound
Parent company	Demant (Denmark, roots to 1904)	GN Hearing (Denmark, roots to 1869)
2026 flagship	Oticon Intent	ReSound Nexia
Signature tech	4D Sensor + deep neural network (BrainHearing)	Bluetooth LE Audio + Auracast broadcast
Natural-sound feature	Deep neural network sound scenes (More/Intent)	M&RIE third microphone (ReSound ONE)
Connectivity	Bluetooth, app control (Oticon Companion)	Bluetooth, LE Audio on Nexia
Flagship price (pair)	~$5,000-$7,000	~$4,000-$6,000
Value flagship	Oticon More, ~$3,000-$5,000	OMNIA, ~$3,000-$5,000
Custom in-the-ear option	Oticon Own	ReSound Custom ITE
Same-parent OTC sibling	None — Demant sells no OTC line	Jabra Enhance Select, ~$1,195-$1,995

The case for Oticon

Oticon Intent

Best for automatic, sensor-driven adjustment · ~$5,000-$7,000/pair · RIC, prescription

First hearing aid with 4D Sensor technology — reads head/body movement, conversation, and environment to adjust settings without you touching anything.
Built on Oticon's deep neural network sound processing and BrainHearing philosophy, trained on millions of real-life sound scenes.
Rechargeable lithium-ion battery with Bluetooth Low Energy support.
Custom in-the-ear Oticon Own option available if you'd rather have nothing behind the ear.

Shop Oticon ProWax filters on Amazon →

Once you’re fitted with a prescription pair, wax filters and domes become a recurring purchase, not a one-time one — try Amazon Prime free for 30 days so reorders land in two days instead of a week. Oticon’s biggest practical edge over ReSound is hands-free intelligence: no other brand currently matches the Intent’s sensor-driven automatic adjustment, and the BrainHearing approach behind it is well regarded by audiologists for natural, low-fatigue listening. Read our full Oticon hearing aids review for the complete lineup.

The case for ReSound

ReSound Nexia

Best for connectivity & natural sound · ~$4,000-$6,000/pair · Micro RIE, prescription

One of the first hearing aids built on Bluetooth LE Audio with Auracast-ready broadcast streaming, per GN Hearing.
Sister model ReSound ONE pioneered M&RIE — a third microphone in the ear canal for more natural sound localization.
Very small Micro RIE form factor that sits discreetly behind the ear.
Same GN engineering also powers the OTC Jabra Enhance Select at a fraction of the price.

Shop ReSound accessories on Amazon →

ReSound’s biggest practical edge over Oticon is connectivity plus a built-in cheaper exit ramp: leading-edge Bluetooth LE Audio with public Auracast broadcast support, natural M&RIE sound localization, and — unlike Oticon — a same-parent OTC sibling (Jabra Enhance Select) if you ever want to switch to a self-fitting device without leaving the GN sound platform. Read our full ReSound hearing aids review for the complete lineup.

Which should you buy?

Choose Oticon if you want the most advanced automatic, sensor-driven adjustment on the market, you value the BrainHearing philosophy’s natural, low-fatigue sound, or discretion matters most and you’d consider the custom Oticon Own.
Choose ReSound if future-proof Bluetooth LE Audio and Auracast public broadcast audio matter to you, you want the most natural sound localization via M&RIE, or you’d like the option to switch to a same-parent OTC device later — Jabra Enhance Select — without changing sound platforms.
Choose neither, for now, if your hearing loss is perceived mild-to-moderate and budget matters more than premium AI or connectivity features — a self-fitting OTC pair like the Jabra Enhance Select covers most everyday needs for a fraction of the price, and our best OTC hearing aids ranking covers the rest of that market.

Both brands appear alongside the rest of the field in our best hearing aid brands roundup and our overall best hearing aids ranking. If you’re weighing ReSound against a rival with a dedicated AI noise chip instead, see our ReSound vs Phonak comparison; for Oticon against another Danish-engineered rival, see our Widex vs Oticon comparison.

When to see a professional instead of comparison-shopping

Oticon and ReSound are both prescription devices, so a licensed audiologist is already part of the process — but get evaluated promptly, rather than shopping by spec sheet, if any of these apply:

Your hearing loss is severe, came on suddenly, or affects one ear only — see our severe hearing loss guide as background, then book a medical evaluation.
You have ear pain, drainage, or a history of ear infections.
Your tinnitus is pulsing or one-sided — read our tinnitus guide and see a doctor first.
You’re fitting a child — both Oticon and ReSound make devices that can suit pediatric loss, which needs a pediatric audiologist, not a general comparison article.

The bottom line

There’s no wrong choice between Oticon and ReSound — both are top-five global brands from Danish hearing-care lineages with genuinely different strengths. Oticon’s Intent wins on automatic, sensor-driven adjustment via 4D Sensor technology and the BrainHearing philosophy; ReSound’s Nexia wins on future-proof Bluetooth LE Audio with Auracast and M&RIE natural sound. Expect $2,500-$7,000 per pair from either, fitted by an audiologist, with value-tier options (More, OMNIA) landing closer to the $3,000 PCAST average. The clearest tiebreaker: ReSound’s parent GN also makes the OTC Jabra Enhance Select if you might want a same-platform self-fitting option later — Oticon’s parent Demant sells no OTC line of its own. Otherwise, ask your audiologist to demo both — or browse Oticon and ReSound accessories on Amazon while you decide.